NCT04036617 - Study of NaQuinate in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 18, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

May 30, 2020

Conditions

Osteoporosis

Interventions

DRUG

NaQuinate

SAD cohorts will receive 1 dose between 10-150 mg. MAD cohorts will receive 7 days dosing between 70-150mg

DRUG

Placebo

SAD cohorts will receive 1 dose of placebo between 10-150 mg. MAD cohorts will receive 7 days dosing of placebo between 70-150mg

Trial Locations (1)

RECRUITING

Parexel Early Phase Clinical Unit - London, London